Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Increasing miR-149 reduces hair follicle stem cell growth and hair development by affecting certain cell growth pathways.

RTA 408 cream protects mice from radiation skin damage.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

CDK4 levels affect the number of hair follicle stem cells in mice.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

M30 is a promising treatment for preventing hair loss during chemotherapy.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Localized breast cancer can affect skin and hair.

Inhibiting ODC can prevent UV-induced skin cancer.

A protein called COMP is part of the connective tissue in normal human hair follicles and may be important for hair health.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Researchers found a genetic region that influences the number of coat layers in dogs.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A new DSG4 gene mutation causes hair defects in a young girl.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.